Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
November 2003
2003:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010
News | News in brief | News Features
News
Germany puts faith in big guns as science ministry feels pinch
Germany's research spending will be trimmed next year by about 100 million (US$120 million), dashing hopes that science can escape the impact of the nation's growing fiscal difficulties.
Nature (26 November 2003)
| Full Text |
Promega changes tack in battle over patent
A company that sells an enzyme used in the polymerase chain reaction is suing the corporation that holds a patent on it, alleging that researchers who use the enzyme almost every day are being overcharged.
Nature (26 November 2003)
| Full Text |
US draws up plans to tackle autism
The National Institutes of Health is preparing a research plan for autism, and hopes to cut the condition's prevalence in the United States by a quarter by 2013.
Nature (26 November 2003)
| Full Text |
Russian claims first in magnetic imaging
At the height of the cold war, Vladislav Ivanov was a young lieutenant in the Red Army charged with trying to use nuclear magnetic resonance in water to help with aircraft navigation.
Nature (26 November 2003)
| Full Text |
UK considers plans to shake up clinical trials
An ambitious proposal was made this week to reinvigorate clinical trials in the United Kingdom. And the government looks likely to implement it, at least in some form, in a bid to strengthen Britain's biotechnology and pharmaceutical industries.
Nature (20 November 2003)
| Full Text |
Cornell axes Elsevier journals as prices rise
A top US research university is set to cancel its subscriptions to several hundred scientific journals published by Elsevier in January, in response to spiralling subscription costs.
Nature (20 November 2003)
| Full Text |
Commercial copying charges hit European academics
European academics are chafing under a regulation that will require some of them to pay €20 (US$24) every time they photocopy a journal paper.
Nature (20 November 2003)
| Full Text |
Task force set up to combat threat of political interference
One of the largest health-research institutes in the United States has set up an informal task force to monitor political threats to its funding.
Nature (20 November 2003)
| Full Text |
Whistles blow in vain on bad practice in German research
Blowing the whistle on research misconduct can be a dangerous game in Germany.
Nature (20 November 2003)
| Full Text |
African states pledge increased spending on research
Thirty-four African countries have committed themselves to spending at least 1% of their economic output on science and technology within five years.
Nature (13 November 2003)
| Full Text |
Italy's proposal for technology institute riles researchers
Italy has revealed plans to allocate €1 billion (US$1.2 billion) to set up what the government hopes will become a world-class institute of technology.
Nature (13 November 2003)
| Full Text |
Florida welcomes Scripps as critics predict big-money flop
Florida governor Jeb Bush this week signed legislation that will help to pump $570 million into bringing the Scripps Research Institute to the 'sunshine state'. But critics are already asking if the deal will attract the research jobs and biotechnology companies that its proponents claim.
Nature (06 November 2003)
| Full Text |
US loses allure in foreign students' eyes
The number of foreign students enrolling in US universities stagnated last year and may now be declining for the first time in decades, according to a series of studies released this week.
Nature (06 November 2003)
| Full Text |
New NIH project could be road to ruin for basic research
Some researchers are worried that the ambitious US National Institutes of Health (NIH) Roadmap for Medical Research will give the NIH director authority to set a top-down agenda at the expense of bench scientists.
Nature Medicine (November 2003)
| Full Text |
Taiwanese scientists find genetic link to SARS
A genetic variant in the immune system might render some groups of people more susceptible to severe acute respiratory syndrome (SARS) infection, Taiwanese researchers report.
Nature Medicine (November 2003)
| Full Text |
European researchers up in arms over new clinical trials edict
European researchers are appealing to their national governments to reject a sweeping new directive on clinical trials.
Nature Medicine (November 2003)
| Full Text |
Scientists closing in on true identity of the 'great imitator'
With new genetic technologies and the complete sequence of the human genome, scientists are poised to take a quantum leap in unraveling the mysteries of systemic lupus erythematosus (SLE).
Nature Medicine (November 2003)
| Full Text |
US NHGRI launches chemical attack on drug development gap
The US National Institutes of Health (NIH) has launched a major push into an arena until now almost the sole dominion of drug and biotech companies: the large scale screening of small molecules, both to probe protein function and to develop drug leads.
Nature Biotechnology (November 2003)
| Full Text |
Public–private partnerships boost research on neglected diseases
The charitable sector, by financing early-stage development, has lowered the risk in creating vaccines for diseases prevalent in developing countries. As a result, targeting neglected diseases has now become attractive to biotech companies that are willing to explore new markets.
Nature Biotechnology (November 2003)
| Full Text |
Concerns raised over declining antiinfectives R&D
In mid-September, officials at the US Food and Drug Administration approved daptomycin for clinical treatment of skin infections–a seeming renaissance because it is the first time in decades that a product belonging to a new class of antibiotics gained approval.
Nature (November 2003)
| Full Text |
News in brief
Irish scientists smiling at research cash boost
| Money down the drain' fears for AIDS vaccine trials
| Cancer grant chief denies Harvard bias
| United Nations fails to reach agreement on human cloning
| Singapore slings cash at research centres
| Women struggle towards top of career ladder
| Microsoft cofounder funds mouse brain atlas project
| Nobel Prizes bestowed for MRI, membrane channels
| NIH funds biodefense labs
| The truth about rats and dogs
| Japan calls in scientists
| NAS advises biodefense board
| EBI supports SMEs
| Regeneron, Aventis strike deal
| Ultimate DNA microarray competition heats up |
News Features
Competition in biology: It's a scoop!
In the highly competitive world of cell and molecular biology, there are no prizes for coming second. But is the pressure to be the first to publish 'hot' results distorting scientific progress? Helen Pearson investigates.
Nature (20 November 2003)
| Full Text |
Intellectual property: This protein belongs to...
The early days of genomics were marked by concerns that wide-ranging gene patents would restrict research and medical discovery. So far, proteomics hasn't toiled under the same cloud. But don't get complacent, warns David Cyranoski.
Nature (06 November 2003)
| Full Text |
The color of money
As the line between academia and industry blurs, conflict-of-interest issues have gone from black and white to all the shades in between.
Nature Medicine (November 2003)
| Full Text |
|
